Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

J Patrick Mahaffy


  • Director at Flexion Therapeutics Inc (FLXN), 2020-06-12
  • President And Ceo at Clovis Oncology Inc. (CLVS), 2020-02-19
  • Director at Orexigen Therapeutics Inc. (OREX), 2017-07-18
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CLVS $5.60 5,827 Officer, Director 968,787 2019-08-16 Filing
CLVS $5.60 5,100 Officer, Director 962,960 2019-08-16 Filing
CLVS $5.59 11,053 Officer, Director 957,860 2019-08-16 Filing
CLVS $5.59 3,700 Officer, Director 946,807 2019-08-16 Filing
CLVS $5.58 11,314 Officer, Director 943,107 2019-08-16 Filing